Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Rankning i aktier #34057
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Aktiekurs
$0.223
Senast synkroniserad: 2026-08-14
Marknadsvärde
$6.32M
Förändring (1 dag)
1.64%
Förändring (1 år)
-
Land
US
Handel Curanex Pharmaceuticals Inc Common Stock (CURX)

Kategori

Utdelningsavkastning för Curanex Pharmaceuticals Inc Common Stock (CURX)
Utdelningsavkastningen (TTM) för Curanex Pharmaceuticals Inc Common Stock (aktiesymbol: CURX) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Curanex Pharmaceuticals Inc Common Stock (CURX) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter